Shaul Lev-Ran
Biographic Data
| ID | 326097 |
|---|---|
| NAME | Shaul Lev-Ran |
| GIVEN NAMES | Shaul |
| FAMILY NAME | Lev-Ran |
| SIGNATURE | LEV-RAN S |
| AFFILIATIONS | Tel Aviv University |
| VERIFIED | No |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Sociodemographic and clinical correlates of drug testing use among psychedelic users
Background and aims This study explores the factors influencing the use of drug-testing kits as a harm reduction strategy among recreational psychedelic users in Israel. Methods Using an online survey of 422 participants, we collected data on attitudes toward testing psychedelic substances, harm reduction attitudes in the context of testing kits, accessibility to testing kits, and demographic characteristics. Descriptive and correlation analyses …
A Qualitative Investigation Into the Experiences of Medicinal Cannabis Use Among Chronic Pain and PTSD Patients in Israel
In the last two decades, the use of cannabis for medical purposes has become legal in many countries and its use is steadily increasing. One of the most frequently cited reasons for prescribing medicinal cannabis (MC) is management of chronic pain, and in recent years MC has also been used as a treatment of psychiatric conditions such as post-traumatic stress disorder (PTSD). However, little is known about patients' experiences of the long-term p…
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Past use of peyote/mescaline was associated with decreased odds of substance use disorder compared to people who had never used psychedelics before, while past use of LSD or psilocybin was not. It remains unclear whether this difference is due to pharmacological differences between these compounds or simply due to the context in which peyote/mescaline are traditionally taken. Future research should investigate why naturalistic use of different ps…
The Psychedelic Renaissance in Clinical Research
Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize trends in its top-cited articles. Bibliometric analyse…
Why Switch? - Motivations for Self-Substitution of Illegal Drugs
Background Self-substitution is the conscious switch from one drug to another for reasons such as price, availability, desired effect, or perceived benefit of the substitute drug. Purpose/Objectives: This study aimed to describe drug use patterns and motivations associated with substitution. We examined correlates of lifetime substitution among individuals with substance use disorder. Methods: A cross-sectional study of 771 treatment-enrolled ind…
The Association Between Cannabis Use and Perceived Social Support
A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice
This study explored whether personal attitudes toward drug users are associated with professional approaches and whether the association between personal and professional attitudes varies across different mental health professions. Participants (N = 347) included medical (psychiatrists and psychiatric nurses) and other (clinical psychologists and social workers) mental health professions from all 13 mental health centers in Israel. They completed…
A Case of Treating Cathinone Dependence and Comorbid Depression Using Bupropion
Cathinone is a potent CNS stimulant found in khat leaves. Cathinone and synthetic cathinone-derivatives have become popular recreational drugs in recent years, commonly marketed as "legal highs." In addition to acute physical and psychiatric adverse effects, dependence on these substances is a concern. The following case reports describes a young man with cathinone dependence and depression that was treated using bupropion. Bupropion is a cathino…
No prominent works on this page.
A Case of Treating Cathinone Dependence and Comorbid Depression Using Bupropion
Cathinone is a potent CNS stimulant found in khat leaves. Cathinone and synthetic cathinone-derivatives have become popular recreational drugs in recent years, commonly marketed as "legal highs." In addition to acute physical and psychiatric adverse effects, dependence on these substances is a concern. The following case reports describes a young man with cathinone dependence and depression that was treated using bupropion. Bupropion is a cathino…
Why Switch? - Motivations for Self-Substitution of Illegal Drugs
Background Self-substitution is the conscious switch from one drug to another for reasons such as price, availability, desired effect, or perceived benefit of the substitute drug. Purpose/Objectives: This study aimed to describe drug use patterns and motivations associated with substitution. We examined correlates of lifetime substitution among individuals with substance use disorder. Methods: A cross-sectional study of 771 treatment-enrolled ind…
The Association Between Cannabis Use and Perceived Social Support
A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice
This study explored whether personal attitudes toward drug users are associated with professional approaches and whether the association between personal and professional attitudes varies across different mental health professions. Participants (N = 347) included medical (psychiatrists and psychiatric nurses) and other (clinical psychologists and social workers) mental health professions from all 13 mental health centers in Israel. They completed…
The Psychedelic Renaissance in Clinical Research
Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize trends in its top-cited articles. Bibliometric analyse…
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Past use of peyote/mescaline was associated with decreased odds of substance use disorder compared to people who had never used psychedelics before, while past use of LSD or psilocybin was not. It remains unclear whether this difference is due to pharmacological differences between these compounds or simply due to the context in which peyote/mescaline are traditionally taken. Future research should investigate why naturalistic use of different ps…
A Qualitative Investigation Into the Experiences of Medicinal Cannabis Use Among Chronic Pain and PTSD Patients in Israel
In the last two decades, the use of cannabis for medical purposes has become legal in many countries and its use is steadily increasing. One of the most frequently cited reasons for prescribing medicinal cannabis (MC) is management of chronic pain, and in recent years MC has also been used as a treatment of psychiatric conditions such as post-traumatic stress disorder (PTSD). However, little is known about patients' experiences of the long-term p…
Sociodemographic and clinical correlates of drug testing use among psychedelic users
Background and aims This study explores the factors influencing the use of drug-testing kits as a harm reduction strategy among recreational psychedelic users in Israel. Methods Using an online survey of 422 participants, we collected data on attitudes toward testing psychedelic substances, harm reduction attitudes in the context of testing kits, accessibility to testing kits, and demographic characteristics. Descriptive and correlation analyses …
Medicine (6 works) · Psychedelics and Drug Studies (6 works) · Psychiatry (6 works) · Psychology (6 works) · Clinical Psychology (4 works) · Cannabis (3 works) · Cannabis and Cannabinoid Research (3 works) · Clinical Psychology (3 works) · Forensic Toxicology and Drug Analysis (3 works) · Internal Medicine (3 works)